Association for Accessible Medicines
FDANonrulemakingFDA-2024-D-4689

Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request

RIN
Last modified
Jun 29, 2026
Comment window
closed 477d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Apr 8, 2025 and Apr 8, 2025. 32 other organizations filed here. The comment window closed 477d ago.

What Association for Accessible Medicines filed (1)

Apr 8, 2025· Comment from Association for Accessible Medicines (AAM)· FDA-2024-D-4689-0079

Comments from the Association for Accessible Medicines (AAM): Considerations for the Use of Artificial Intelligence to Support Regulatory Decision- Making for Drug and Biological Products

Abstract

OPEN

View on regulations.gov →